Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 544 | 674 | 470 | 665 | 329 |
| Gross Profit | 544 | 674 | 470 | 665 | 329 |
| Operating Expenses | 5,493 | 22,294 | 2,828 | -9,912 | 2,263 |
| Operating Income | -4,949 | -21,620 | -2,358 | 10,577 | -1,934 |
| Other Income | 57 | -1,226 | 64 | 711 | 36 |
| Pre-tax Income | -4,892 | -22,846 | -2,294 | 11,288 | -1,898 |
| Net Income Continuous | -4,892 | -22,846 | -2,294 | 11,288 | -1,898 |
| Net Income | $-4,892 | $-22,846 | $-2,294 | $11,288 | $-1,898 |
| EPS Basic Total Ops | -6.40 | -67.60 | -12.40 | 74.37 | -10.60 |
| EPS Basic Continuous Ops | -6.38 | -67.54 | -12.48 | 73.75 | -10.52 |
| EPS Diluted Total Ops | -6.40 | -67.60 | -12.40 | 74.37 | -10.60 |
| EPS Diluted Continuous Ops | -6.38 | -67.54 | -12.48 | 73.75 | -10.52 |
| EBITDA(a) | $-4,949 | $-21,620 | $-2,358 | $10,577 | $-1,934 |